Compumed Inc (CMPDD)

[JohnCM]

CompuMed, Inc
June 30, 2014 – Q3 Quarterly Report

http://www.otcmarkets.com/otciq/ajax/showFinancialReportById.pdf?id=124991

List of Relevant Transactions for this Section:
2/12/13: 1,000,000 common shares sold to W. Scott Rombach, CompuMed’s President, CEO and Director, at a market price of $0.09 per share for total proceeds of $90,000. These shares carry restricted legends.
5/13/13: 750,000 common shares sold to W. Scott Rombach, CompuMed’s President, CEO and Director, at a market price of $0.08 per share for total proceeds of $60,000. These shares carry restricted legends.
6/25/14: 133,333 common shares sold to Dr. John Romm, a former Director, exercised stock option grants, at a grant price of $0.16 per share for total proceeds of $21,333.28. These shares carry no restrictive legends.
6/25/14: 133,333 common shares sold to Dr. John Romm, a former Director, exercised stock option grants, at a grant price of $0.16 per share for total proceeds of $21,333.28. These shares carry no restrictive legends.
6/26/14: 250,000 common shares sold to Robert Stuckelman, former Director, exercised stock option grants, at a grant price of $0.16 per share for total proceeds of $40,000. These shares carry no restrictive legends.
6/27/14: 200,000 common shares sold to Dr. Stuart Silverman, a former Director, exercised stock option grants, at a grant price of $0.16 per share for total proceeds of $32,000. These shares carry no restrictive legends.